Aura Biosciences, Inc.
Biotechnology company · Boston, Massachusetts, United States · Nasdaq: AURA
Aura Biosciences, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2009. Its shares trade on Nasdaq under the ticker AURA. It has reported private securities offerings to the US SEC, most recently $80 million sold in a notice filed in 2021.
Aura Biosciences at a glance
What does Aura Biosciences do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $80.5 million sold (2021).
Frequently asked questions about Aura Biosciences
Where is Aura Biosciences headquartered?
Aura Biosciences, Inc. is headquartered in Boston, Massachusetts, United States.
What does Aura Biosciences do?
Aura Biosciences, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Aura Biosciences a public company?
Yes. Aura Biosciences, Inc. trades on Nasdaq under the ticker AURA.
When was Aura Biosciences founded?
The earliest incorporation on record for Aura Biosciences, Inc. is in 2009, according to public company registers.
Similar companies
- Elucid Bioimaging Inc.Boston, Massachusetts, United States
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.